Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports

Fig. 2

a One-stage IPD meta-analysis of Risperidone efficacy according to total PANSS. MD, mean difference; 95% CI, 95% confidence interval; REML, restricted maximum likelihood. b One-stage IPD meta-analysis of Paliperidone efficacy according to total PANSS. MD, mean difference; 95% CI, 95% confidence interval; REML, restricted maximum likelihood. c One-stage IPD meta-analysis of Paliperidone palmitate efficacy according to total PANSS. MD, mean difference; 95% CI, 95% confidence interval; REML, restricted maximum likelihood

Back to article page